---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-001979"
form_type: "8-K"
ticker: "SLSN"
cik: "0000883107"
company_name: "SOLESENCE, INC."
filed_at: "2023-03-29T23:59:59+00:00"
generated_at: "2026-06-17T11:34:29.048165+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nanophase reports record FY2022 revenue $37.3M (+27% YoY) but net loss of $2.6M

## Summary
- FY2022 revenue $37.3M, up 27% YoY; Q4 revenue $8.3M, up 12% YoY.
- Net loss $2.6M ($0.05/sh) vs net income $2.3M ($0.05/sh) in 2021.
- Solésence revenue $23.1M (+27%); Personal Care Ingredients $11.1M (+44%); Advanced Materials $3.1M (-14%).
- Atypical expenses $1.6M: $0.7M cyber theft loss, $0.4M litigation legal fees, $0.3M bad debt.
- Received US patent allowance for Kleair skin health tech; named No.2 in Fast Company Beauty innovation list.

## SEC filing metadata
- accession: 0001171843-23-001979
- form_type: 8-K
- ticker: SLSN
- cik: 0000883107
- company_name: SOLESENCE, INC.
- filed_at: 2023-03-29T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883107/000117184323001979/0001171843-23-001979-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883107/000117184323001979/f8k_032923.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-001979
- JSON: https://secwatch.observer/filing/0001171843-23-001979.json
- Plain text: https://secwatch.observer/filing/0001171843-23-001979.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.